News

In the first successful United States trial of a bioabsorbable polymer stent, the Boston Scientific Synergy everolimus-eluting bioabsorbable polymer platinum chromium coronary stent system met its primary endpoint in this non-inferiority study, which evaluated the one-year rate of target lesion failure (TLF).

Home December 10, 2014
Home
Technology

Medtronic Inc. announced the launch in Europe and the United States of the Endurant IIs AAA stent graft, which received CE mark and U.S. Food and Drug Administration approval to be used in the minimally invasive treatment of abdominal aortic aneurysms (AAA).

Home December 10, 2014
Home
Technology

Stethoscope provides high acoustic sensitivity for performing general physical assessments

Home December 10, 2014
Home
Technology

Siemens Healthcare plans to expand its portfolio of magnetic resonance imaging (MRI) systems to include the Magnetom Amira 1.5 Tesla system, which the company introduced at RSNA 2014.

Home December 10, 2014
Home
News

CardioKinetix Inc. announced it has completed a $50 million financing led by Edwards Lifesciences Corp. with participation from other existing investors. This financing provides CardioKinetix with the capital necessary to complete the PARACHUTE IV randomized pivotal clinical trial of the Parachute ventricular partitioning device for the treatment of heart failure.

Home December 09, 2014
Home
near-infrared spectroscopy, NIRS, heart attack, stroke, Infraredx, TVC
Feature

A study published in the Journal of the American College of Cardiology (JACC) shows intravascular near-infrared spectroscopy (NIRS) can identify lipid core-containing plaques, implicated in most heart attacks. The study shows the technology might be used as a means to predict the risk of future major adverse cardiac and cerebrovascular events (MACCE).

Home December 09, 2014
Home
News

CardioCell LLC announced the treatment of its first patient in the University of Pennsylvania’s Phase IIa clinical trial for chronic heart failure (HF) of non-ischemic cardiomyopathy.

Home December 09, 2014
Home
Technology

Turner MedTech introduced ClearShield at RSNA, which is lead-free, eco-friendly, utilizes no lead and complies with European Union RoHS requirements.

Home December 09, 2014
Home
Technology

COR Medical Technologies (COR) introduces CORcare, a comprehensive instant outcome support system for rapid and accurate diagnosis, treatment, and follow-up management of patients with acute and chronic, common and rare diseases involving the cardiovascular system.

Home December 08, 2014
Home
News

Children’s hospitals in the United States delivering the highest-quality care for children undergoing heart surgery also appear to provide care most efficiently at a low cost, according to research led by the University of Michigan and presented at the American Heart Association Scientific Sessions in Chicago.

Home December 08, 2014
Home
News

Researchers at the Minneapolis Heart Institute Foundation have found that when care teams started following a new set of guidelines for certain patients recovering from cardiovascular surgery, hospital stays (and the associated costs) were reduced.

Home December 08, 2014
Home
News

Breathing secondhand marijuana smoke could damage heart and blood vessels as much as secondhand cigarette smoke, according to preliminary research presented at the American Heart Association’s Scientific Sessions 2014.

Home December 08, 2014
Home
News

BioCardia Inc. announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s application to begin a Phase III clinical trial of its bone marrow-derived CardiAMP Therapy for heart failure. The clinical trial is a randomized, controlled, multi-center study of 250 patients evaluating CardiAMP Therapy at up to 40 clinical sites.

Home December 05, 2014
Home
News

Most patients with implantable cardioverter defibrillators (ICDs) haven’t thought about device deactivation if they were to develop a serious illness from which they were not expected to recover.

Home December 05, 2014
Home
News

Researchers reported on a procedure that can preserve fertility and potentially save the lives of women with a serious pregnancy complication called placenta accreta. Results of the new study presented at the annual meeting of the Radiological Society of North America (RSNA) showed that placement of balloons in the main artery of the mother's pelvis prior to a Caesarean section protects against hemorrhage and is safe for both mother and baby.

Home December 05, 2014
Home
Subscribe Now